Agrawal Drugs Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 1988.
1988 Delhi, Delhi, India Active
Last Updated:
Access Report
About Agrawal Drugs Private Limited

Agrawal Drugs Private Limited, a active private limited company, was established on 13 March 1988 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899DL1988PTC031163. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹3.81 M.

It upholds a compliant status. Employing 55 professional, Its leadership includes Nidhi Agrawal (Director), Ashok Agrawal (Managing Director), Ranjana Goyal (Director). Past directors included Ashok Agrawal, Kailash Chandra Agrawal, Sumeet Agrawal. It holds ₹16.31 Cr open charges and ₹6.80 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.-300 F.I.E., Patparganj Industrial Area, Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1988PTC031163

  • Registration Number

    031163

  • Incorporation Date

    13 March 1988

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹3.81 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 3.81 M
  • Company Age 37 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 16.31 Cr
  • Satisfied Charges ₹ 6.80 Cr
  • Revenue Growth **** -99.21%
  • Profit Growth **** -99.59%
  • Ebitda **** -99.52%
  • Net Worth -98.92%
  • Total Assets -98.93%
Company report

Agrawal Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Agrawal Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Agrawal Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Nidhi Agrawal Director 14 Jul 2005 Current
Ashok Agrawal Managing Director 14 Jul 2005 Current
Ranjana Goyal Director 22 Jun 1998 Current
Sumeet Agrawal Managing Director 16 Feb 2001 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Nov 2017 Past
Pramod Abcsdd Director 22 May 2016 Past
Pramod Abcsdd Director 01 Apr 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Agrawal Drugs.

Agrawal Drugs Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.21% decrease. The company also saw a substantial fall in profitability, with a 99.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 98.92%.

Agrawal Drugs revenue growth over time
Agrawal Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -99.21%
*******
*******
*******
*******
Revenue from Operations
*******
 -99.21%
*******
*******
*******
*******
Total Assets
*******
 -98.93%
*******
*******
*******
*******
Profit or Loss
*******
 -99.59%
*******
*******
*******
*******
Net Worth
*******
 -98.92%
*******
*******
*******
*******
EBITDA
*******
 -99.52%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Agrawal Drugs?

Unlock access to Agrawal Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹163,137,958.00

Satisfied Charges

₹67,950,300.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 15.36 Cr
  • Sidbi : 0.95 Cr
Latest Charge Details
Date Lender Amount Status
25 Apr 2025 Hdfc Bank Limited ₹2.00 M Open
24 Jan 2024 Hdfc Bank Limited ₹1.61 M Open
25 Jan 2023 Sidbi ₹4.53 M Open
30 Mar 2020 Sidbi ₹5.00 M Open
17 Jun 2019 Hdfc Bank Limited ₹15.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Agrawal Drugs?

Agrawal Drugs has a workforce of 55 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Agrawal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agrawal Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Agrawal Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Agrawal Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 2.00 M with Charge ID 101090786 was registered on 25 Apr 2025. was completed.

  • Balance Sheet

    Progress on Agrawal Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 150.00 M registered on 17 Jun 2019 with Charge ID 100269980 was modified on 10 Mar 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 1.61 M with Charge ID 100864830 was registered on 24 Jan 2024. was completed.

  • Charges

    A charge with Sidbi amounted to Rs. 4.53 M with Charge ID 100679863 was registered on 25 Jan 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Agrawal Drugs Private Limited?

The CIN of Agrawal Drugs Private Limited is U74899DL1988PTC031163.

Where is Agrawal Drugs Private Limited headquartered?

Agrawal Drugs Private Limited is headquartered at Plot No.-300 F.I.E., Patparganj Industrial Area, Delhi, Delhi, 110092.

When was Agrawal Drugs Private Limited incorporated?

Agrawal Drugs Private Limited was incorporated on 13 March 1988.

Who are the current directors of Agrawal Drugs Private Limited?

The current directors of Agrawal Drugs Private Limited are

What is the primary industry of Agrawal Drugs Private Limited?

The primary industry of Agrawal Drugs Private Limited is Manufacturing.

Is Agrawal Drugs Private Limited a listed company?

Agrawal Drugs Private Limited is unlisted.

What is the capital structure of Agrawal Drugs Private Limited?

The authorized capital of Agrawal Drugs Private Limited is ₹5.00 M, and the paid-up capital is ₹3.81 M.

What is the compliance status of Agrawal Drugs Private Limited?

The compliance status of Agrawal Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available